Lateral Quadratus Lumborum Block vs Intrathecal Morphine for Cesarean Section analgesia
Official title: Comparison of the Analgesic Efficacy of Lateral Quadratus Lumborum Block and Intrathecal Morphine for Postoperative Pain Management Following Cesarean Delivery Under Spinal Anesthesia: A Randomized Controlled Trial
Run by Ondokuz Mayıs University · NCT07712783 · Data updated 2026-11-12
This study tests whether a lateral quadratus lumborum block can provide pain relief after cesarean delivery as effectively as intrathecal morphine.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 56 (estimated) |
| Sponsor | Ondokuz Mayıs University Academic / other |
| Locations | 1 site (Samsun) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07712783 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18-45 undergoing elective cesarean delivery with spinal anesthesia and meeting inclusion criteria.
✕Probably not a fit
Patients not experiencing adequate analgesia from QLB-I or who have contraindications to regional blocks may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, non-inferiority trial compares ultrasound-guided lateral QLB-I with intrathecal morphine for post-cesarean analgesia. Primary outcome focuses on analgesic efficacy, with secondary outcomes including opioid use after surgery, pain scores, opioid-related side effects, quality of recovery, and maternal satisfaction. The trial targets term, healthy-appearing, singleton pregnancies undergoing elective cesarean with spinal anesthesia. It aims to determine if QLB-I can match ITM in pain control while potentially reducing opioid-related adverse events. Safety monitoring aligns with standard perioperative analgesia trials.
Why it matters
Potential benefit: If successful, QLB-I could provide effective pain relief with fewer opioid-related side effects, improving recovery and breastfeeding.
How similar studies have gone: Prior QLB approaches have shown promise for abdominal surgery, but the direct non-inferiority comparison to ITM in cesarean patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged between 18 and 45 years. * Singleton term pregnancy (≥37 weeks of gestation). * American Society of Anesthesiologists (ASA) physical status II. * Scheduled to undergo elective cesarean delivery via a Pfannenstiel incision. * Planned to receive spinal anesthesia for cesarean delivery. * Provision of written informed consent following a comprehensive explanation of the study. * Sufficient cognitive capacity to understand and complete the study assessment instruments, including the Numeric Rating Scale (NRS) and the ObsQoR-11T. Exclusion Criteria: * Known allergy or hypersensitivity to any of the study medications, including morphine, bupivacaine, or fentanyl. * Coagulopathy (international normalized ratio \[INR\] \>1.5 or platelet count \<100,000/mm³). * Current treatment with anticoagulant or antiplatelet agents (e.g., heparin, low-molecular-weight heparin, or aspirin \>100 mg/day). * Infection, hematoma, or skin lesion at the planned block insertion site. * Diagnosis of preeclampsia, eclampsia, or HELLP syndrome. * Placenta previa, placenta accreta spectrum, or placental abruption. * Gestational diabetes mellitus or chronic hypertension. * Emergency cesarean delivery indicated because of fetal distress. * Conversion to general anesthesia during cesarean delivery. * History of chronic pain syndrome (e.g., fibromyalgia, lumbar disc herniation, or neuropathic pain). * Regular use of opioids or psychotropic medications within the preceding 3 months. * Diagnosis of epilepsy, severe anxiety disorder, or major depressive disorder. * Obesity (body mass index \>35 kg/m²). * Severe systemic disease, including New York Heart Association (NYHA) class III or IV heart failure, hepatic or renal failure, advanced respiratory disease, or obstructive sleep apnea. * Advanced pulmonary disease requiring continuous positive airway pressure (CPAP) therapy. * Inadequate spinal anesthesia or the requirement for supplemental intraoperative analgesia. * Surgical duration exceeding 120 minutes. * Excessive intraoperative blood loss (≥1,000 mL) or the need for blood transfusion.
Where it's running
-
Ondokuz Mayis University
Samsun, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Burhan Dost — Ondokuz Mayıs University
- Study coordinator: Burhan Dost
- Email: burhandost@hotmail.com
- Phone: +903623121919
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparison of meta-PENG vs suprainguinal fascia iliaca block for hip fracture pain
This study tests whether two ultrasound-guided nerve blocks help with pain control for adults having hip fracture surgery under spinal anesthesia.
-
DIPB vs SIFIB for pain control after total hip replacement
This will test whether the Deep Iliacus Plane Block (DIPB) or the Suprainguinal Fascia Iliaca Block (SIFIB) gives better pain relief and less leg weakness for adults having elective total hip replacement.
-
Regional anesthesia for knee replacement: effects on early joint motion and patient satisfaction
We will test whether three different regional anesthesia approaches — an epidural catheter, an adductor canal catheter, or multimodal IV pain control — help adults having elective knee replacement move their knee better and feel more satisfied after surgery.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.